ReviewChest2022

Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia.

Ari Moskowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.